secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rapport Therapeutics, Inc. (RAPP)
CIK:        0002012593
Form:       8-K
Filed at:   2025-09-10T23:59:59+00:00
Accession:  0001193125-25-200205
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapport Therapeutics announces $234.7M public offering of 9.6M shares at $26.00 per share
--------------------------------------------------------------------------------

- Underwriting agreement for 9,615,385 shares at $26.00; underwriters option for up to 1,442,307 additional shares.
- Net proceeds estimated at $234.7 million (excluding over-allotment).
- Proceeds to fund RAP-219 clinical trials, R&D, and working capital.
- Closing expected on or about September 11, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/0001193125-25-200205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2012593/000119312525200205/d907117d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-200205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer